46.46.Z - Wholesale trade of pharmaceutical and medical products
46.51 - Wholesale trade
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,8 | 1295,1 |
EBITDA | 0,1 | 0,8 | 1300,3 |
Short time liabilities | 0,1 | 8,5 | 16 160,9 |
Equity capital | 0,1 | 0,7 | 1102,7 |
Operating profit (EBIT) | 0,1 | 0,8 | 1300,3 |
Assets | 0,1 | 9,1 | 8443,6 |
Net profit (loss) | 0 | 0,6 | 1114,6 |
Cash | 0,1 | 6,7 | 11 310,1 |
Liabilities and provisions for liabilities | 0,1 | 8,5 | 16 160,9 |
Net income from sale | 1,3 | 15,2 | 1042,1 |
Working assets | 0,1 | 9,1 | 8443,6 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 90,8 | 91,7 | 0,9 |
Equity capital to total assets | 51,1 | 7,2 | -43,9 |
Gross profit margin | 4,1 | 5 | 0,9 |
EBITDA Margin | 4,1 | 5 | 0,9 |
Days | Days | Days | |
Short term commitment turnover cycle | 14 | 204 | 190 |
Current financial liquidity indicator | 2.043290853500366 | 1.0735623836517334 | -0,9 |
Net dept to EBITDA | -0.7174102663993835 | -8.856114387512207 | -8,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane